Gülsüm Altuntaş
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Gülsüm Altuntaş has a total of 155 co-authors. Here are the top co-authors by number of shared publications:
- Aysun Yıldız Altun
Department of Anesthesilogy and Reanimation, Fırat University, Elâzığ, Turkey
5 shared publications - Emine Büşra Berilgen Kaya
Department of Anesthesilogy and Reanimation, Yeşilyurt Hasan Çalık State Hospital, Malatya, Turkey.
4 shared publications - Ahmet Aksu
Department of Anesthesiology and Reanimation, Faculty of Medicine, Fırat University, 23119 Elazığ, Türkiye
3 shared publications - Fatma Çelik
Department of Anesthesiology and Reanimation, Faculty of Medicine, Fırat University, Elazığ, Turkiye
3 shared publications - Ismail Demirel
Intensive Care Unit, Department of Anesthesiology and Reanimation, Firat University School of Medicine Hospital, Elazig 23119, Turkey
3 shared publications - Adil Karaturna2 shared publications
Latest Publications
- 10 July 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (8) , 4378-4387
Effects of Pneumoperitoneum Pressure on Optic Nerve Sheath Diameter, Cerebral Oxygenation, and Postoperative Recovery During Laparoscopic Sleeve Gastrectomy: A Randomized Controlled Trial
Background Carbon dioxide (CO₂) pneumoperitoneum during laparoscopic surgery may increase intracranial pressure by impairing cerebral venous drainage and inducing cerebral vasodilation. Patients with severe obesity may be particularly vulnerable due to obesity-related cardiopulmonary and hemodynamic alterations. This randomized controlled trial investigated the effects of standard- versus high-pressure pneumoperitoneum on optic nerve sheath diameter (ONSD), regional cerebral oxygen saturation (rSO₂), and postoperative recovery in patients undergoing laparoscopic sleeve gastrectomy (LSG). Methods Sixty-three patients with severe obesity undergoing LSG were randomly allocated to standard-pressure pneumoperitoneum (PP12, 12 mmHg; n = 31) or high-pressure pneumoperitoneum (PP15, 15 mmHg; n = 32). The primary outcome was intraoperative change in ONSD, assessed by ultrasonography at predefined time points. Regional cerebral oxygen saturation was monitored continuously using near-infrared spectroscopy. Hemodynamic variables, PONV, pain scores, opioid requirements, and gastrointestinal recovery were also evaluated. Participants and postoperative assessors were blinded to group allocation. Results ONSD increased during pneumoperitoneum in both groups, with significantly greater elevation in the PP15 group at 30 min. Cerebral oxygenation and hemodynamic parameters remained comparable throughout. The PP15 group experienced higher PONV rates, increased opioid consumption, greater postoperative pain scores, and delayed gastrointestinal recovery. Conclusion High-pressure pneumoperitoneum was associated with transient ONSD elevation and less favorable postoperative recovery despite preserved cerebral oxygenation. Low-pressure pneumoperitoneum may represent a simple, ERAS-compatible strategy to improve postoperative outcomes while maintaining cerebral safety in patients with severe obesity.
- 10 July 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (8) , 4378-4387
Effects of Pneumoperitoneum Pressure on Optic Nerve Sheath Diameter, Cerebral Oxygenation, and Postoperative Recovery During Laparoscopic Sleeve Gastrectomy: A Randomized Controlled Trial
Background Carbon dioxide (CO₂) pneumoperitoneum during laparoscopic surgery may increase intracranial pressure by impairing cerebral venous drainage and inducing cerebral vasodilation. Patients with severe obesity may be particularly vulnerable due to obesity-related cardiopulmonary and hemodynamic alterations. This randomized controlled trial investigated the effects of standard- versus high-pressure pneumoperitoneum on optic nerve sheath diameter (ONSD), regional cerebral oxygen saturation (rSO₂), and postoperative recovery in patients undergoing laparoscopic sleeve gastrectomy (LSG). Methods Sixty-three patients with severe obesity undergoing LSG were randomly allocated to standard-pressure pneumoperitoneum (PP12, 12 mmHg; n = 31) or high-pressure pneumoperitoneum (PP15, 15 mmHg; n = 32). The primary outcome was intraoperative change in ONSD, assessed by ultrasonography at predefined time points. Regional cerebral oxygen saturation was monitored continuously using near-infrared spectroscopy. Hemodynamic variables, PONV, pain scores, opioid requirements, and gastrointestinal recovery were also evaluated. Participants and postoperative assessors were blinded to group allocation. Results ONSD increased during pneumoperitoneum in both groups, with significantly greater elevation in the PP15 group at 30 min. Cerebral oxygenation and hemodynamic parameters remained comparable throughout. The PP15 group experienced higher PONV rates, increased opioid consumption, greater postoperative pain scores, and delayed gastrointestinal recovery. Conclusion High-pressure pneumoperitoneum was associated with transient ONSD elevation and less favorable postoperative recovery despite preserved cerebral oxygenation. Low-pressure pneumoperitoneum may represent a simple, ERAS-compatible strategy to improve postoperative outcomes while maintaining cerebral safety in patients with severe obesity.
- 1 July 2026
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 17 (7) , 724-728
Morbidity, mortality, and ICU stay after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
Aim Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) is a comprehensive treatment approach for primary peritoneal cancers and peritoneal metastases from colorectal, appendiceal, ovarian, gastric, and other malignancies. This study aimed to evaluate clinical outcomes, perioperative complications, and their impact on morbidity and mortality in patients undergoing CRS and HIPEC. Methods A retrospective analysis was conducted on patients who underwent CRS and HIPEC. Demographic characteristics, primary diagnoses, comorbidities, laboratory findings, surgical details, and chemotherapeutic agents were recorded. Perioperative hemodynamic changes, fluid and blood product use, need for postoperative intensive care and mechanical ventilation, and renal injury were assessed. ICU stay duration and mortality rates were documented. Results A total of 41 patients were included. The most common primary diagnosis was ovarian cancer (65.9%), followed by colon cancer (17.1%) and mesothelioma (14.6%). Chemotherapeutic agents administered included cisplatin (78%), paclitaxel (46.3%), doxorubicin (14.6%), oxaliplatin (14.6%), and 5-FU (12.2%). Most patients (87.8%) were extubated postoperatively, and 90.2% required ICU follow-up. The mean ICU stay was 4.3 ± 1.5 days. Acute kidney injury occurred in 21.9% of patients. One-month postoperative mortality was 12.2%, and total mortality at 15 months was 24.4%. Conclusion CRS and HIPEC are associated with significant perioperative physiological changes. Successful outcomes require meticulous perioperative management, particularly in terms of hemodynamic stability and organ function support.
- 1 July 2026
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 17 (7) , 724-728
Morbidity, mortality, and ICU stay after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
Aim Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) is a comprehensive treatment approach for primary peritoneal cancers and peritoneal metastases from colorectal, appendiceal, ovarian, gastric, and other malignancies. This study aimed to evaluate clinical outcomes, perioperative complications, and their impact on morbidity and mortality in patients undergoing CRS and HIPEC. Methods A retrospective analysis was conducted on patients who underwent CRS and HIPEC. Demographic characteristics, primary diagnoses, comorbidities, laboratory findings, surgical details, and chemotherapeutic agents were recorded. Perioperative hemodynamic changes, fluid and blood product use, need for postoperative intensive care and mechanical ventilation, and renal injury were assessed. ICU stay duration and mortality rates were documented. Results A total of 41 patients were included. The most common primary diagnosis was ovarian cancer (65.9%), followed by colon cancer (17.1%) and mesothelioma (14.6%). Chemotherapeutic agents administered included cisplatin (78%), paclitaxel (46.3%), doxorubicin (14.6%), oxaliplatin (14.6%), and 5-FU (12.2%). Most patients (87.8%) were extubated postoperatively, and 90.2% required ICU follow-up. The mean ICU stay was 4.3 ± 1.5 days. Acute kidney injury occurred in 21.9% of patients. One-month postoperative mortality was 12.2%, and total mortality at 15 months was 24.4%. Conclusion CRS and HIPEC are associated with significant perioperative physiological changes. Successful outcomes require meticulous perioperative management, particularly in terms of hemodynamic stability and organ function support.
- 1 May 2026
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 17 (5) , 418-421
Evaluation of surgical and anesthesiology physicians’ approaches to preoperative medication management: a two-center survey study
Aim This study aimed to evaluate the approaches of surgical and anesthesiology physicians toward the management of medications used during the preoperative period and to raise awareness about standardizing these practices to minimize perioperative complications. Methods After ethical approval, a web-based 27-question survey was distributed between April and July 2023 to surgeons and anesthesiologists working at Fırat University Faculty of Medicine Hospital and Elazığ Fethi Sekin City Hospital. The questionnaire assessed demographic characteristics and clinical approaches to preoperative medication management. Descriptive statistical methods were used for data analysis. Results A total of 83 physicians participated; 69.8% were from Fırat University and 30.1% from Elazığ Fethi Sekin City Hospital. Of them, 61.7% reported having a preoperative medication management protocol. Antiplatelet/anticoagulant drugs were the most frequently questioned group (39.8%), while only 4.8% asked about herbal medicine use. Nearly half (49.4%) always discontinued antiplatelet/anticoagulants, mostly one week before surgery. In contrast, 72% continued NSAIDs and 84.1% continued antihypertensive medications. Antidepressants were stopped by 79.5% of participants, and herbal products were questioned by only 39.8%. Conclusion Although physicians were generally aware of preoperative medication management principles, significant inconsistencies were observed between knowledge and practice. Decisions were largely based on individual experience rather than evidence-based guidelines. Particularly, limited awareness regarding herbal and psychotropic agents may increase perioperative risk. Standardized institutional protocols and continuous education are needed to improve patient safety and surgical outcomes.
- 1 May 2026
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 17 (5) , 418-421
Evaluation of surgical and anesthesiology physicians’ approaches to preoperative medication management: a two-center survey study
Aim This study aimed to evaluate the approaches of surgical and anesthesiology physicians toward the management of medications used during the preoperative period and to raise awareness about standardizing these practices to minimize perioperative complications. Methods After ethical approval, a web-based 27-question survey was distributed between April and July 2023 to surgeons and anesthesiologists working at Fırat University Faculty of Medicine Hospital and Elazığ Fethi Sekin City Hospital. The questionnaire assessed demographic characteristics and clinical approaches to preoperative medication management. Descriptive statistical methods were used for data analysis. Results A total of 83 physicians participated; 69.8% were from Fırat University and 30.1% from Elazığ Fethi Sekin City Hospital. Of them, 61.7% reported having a preoperative medication management protocol. Antiplatelet/anticoagulant drugs were the most frequently questioned group (39.8%), while only 4.8% asked about herbal medicine use. Nearly half (49.4%) always discontinued antiplatelet/anticoagulants, mostly one week before surgery. In contrast, 72% continued NSAIDs and 84.1% continued antihypertensive medications. Antidepressants were stopped by 79.5% of participants, and herbal products were questioned by only 39.8%. Conclusion Although physicians were generally aware of preoperative medication management principles, significant inconsistencies were observed between knowledge and practice. Decisions were largely based on individual experience rather than evidence-based guidelines. Particularly, limited awareness regarding herbal and psychotropic agents may increase perioperative risk. Standardized institutional protocols and continuous education are needed to improve patient safety and surgical outcomes.
- 31 March 2026
- Published by Academician Publishing
- p. 275-280
Yoğun Bakım Ünitesinde Hellp Sendromuna Yaklaşım
HELLP sendromu (Hemoliz, Elevated Liver enzymes, Low Platelet count), gebeliğin özellikle üçüncü trimesterinde veya postpartum dönemde görülen, maternal ve fetal morbidite ile mortaliteyi artıran ciddi bir obstetrik acil durumdur. Genellikle preeklampsi ile ilişkili olarak ortaya çıkar, ancak bazı olgularda preeklampsi bulgusu olmadan da gelişebilir. Tanı, laboratuvar parametrelerine dayanmakta olup; hemoliz, karaciğer enzimlerinde yükselme ve trombositopeni ile karakterizedir. Klinik spektrum oldukça değişken olup hafif vakalardan çoklu organ yetmezliğine kadar ilerleyebilen tablolara neden olabilir. Bu bölümde, postpartum dönemde gelişen ve çoklu organ disfonksiyonu ile seyreden Class 1 HELLP sendromu olgusu sunulmuştur. Hasta, sezaryen sonrası erken dönemde oligüri, ciddi trombositopeni, karaciğer enzimlerinde belirgin artış ve renal fonksiyon bozukluğu nedeniyle yoğun bakıma alınmıştır. İlk tedavilere yanıt alınamaması üzerine uygulanan plazmaferez ve hemodiyaliz tedavileri ile hastada klinik ve laboratuvar iyileşme sağlanmış, yoğun bakım süreci komplikasyonsuz tamamlanarak taburculuk gerçekleştirilmiştir. Bu olgu, şiddetli HELLP sendromu vakalarının yönetiminde multidisipliner yaklaşımın ve ileri organ destek tedavilerinin önemini vurgulamaktadır. HELLP syndrome (Hemolysis, Elevated Liver enzymes, Low Platelet count) is a life-threatening obstetric emergency typically occurring during the third trimester or postpartum period. It is often associated with preeclampsia, although it may also develop independently. The diagnosis is based on laboratory findings, characterized by hemolysis, elevated liver enzymes, and thrombocytopenia. The clinical presentation can vary widely, ranging from mild symptoms to severe cases involving multi-organ dysfunction. In this chapter, we present a case of Class 1 HELLP syndrome that developed in the postpartum period and progressed to multi-organ failure. The patient was admitted to the intensive care unit (ICU) shortly after cesarean delivery due to oliguria, severe thrombocytopenia, marked elevation in liver enzymes, and acute renal impairment. As initial treatment modalities failed to stabilize her condition, plasmapheresis and hemodialysis were initiated, leading to significant clinical and laboratory improvement. The patient recovered without complications and was successfully discharged. This case emphasizes the importance of a multidisciplinary approach and advanced organ support therapies in managing severe HELLP syndrome.
- 31 March 2026
- Published by Academician Publishing
- p. 275-280
Yoğun Bakım Ünitesinde Hellp Sendromuna Yaklaşım
HELLP sendromu (Hemoliz, Elevated Liver enzymes, Low Platelet count), gebeliğin özellikle üçüncü trimesterinde veya postpartum dönemde görülen, maternal ve fetal morbidite ile mortaliteyi artıran ciddi bir obstetrik acil durumdur. Genellikle preeklampsi ile ilişkili olarak ortaya çıkar, ancak bazı olgularda preeklampsi bulgusu olmadan da gelişebilir. Tanı, laboratuvar parametrelerine dayanmakta olup; hemoliz, karaciğer enzimlerinde yükselme ve trombositopeni ile karakterizedir. Klinik spektrum oldukça değişken olup hafif vakalardan çoklu organ yetmezliğine kadar ilerleyebilen tablolara neden olabilir. Bu bölümde, postpartum dönemde gelişen ve çoklu organ disfonksiyonu ile seyreden Class 1 HELLP sendromu olgusu sunulmuştur. Hasta, sezaryen sonrası erken dönemde oligüri, ciddi trombositopeni, karaciğer enzimlerinde belirgin artış ve renal fonksiyon bozukluğu nedeniyle yoğun bakıma alınmıştır. İlk tedavilere yanıt alınamaması üzerine uygulanan plazmaferez ve hemodiyaliz tedavileri ile hastada klinik ve laboratuvar iyileşme sağlanmış, yoğun bakım süreci komplikasyonsuz tamamlanarak taburculuk gerçekleştirilmiştir. Bu olgu, şiddetli HELLP sendromu vakalarının yönetiminde multidisipliner yaklaşımın ve ileri organ destek tedavilerinin önemini vurgulamaktadır. HELLP syndrome (Hemolysis, Elevated Liver enzymes, Low Platelet count) is a life-threatening obstetric emergency typically occurring during the third trimester or postpartum period. It is often associated with preeclampsia, although it may also develop independently. The diagnosis is based on laboratory findings, characterized by hemolysis, elevated liver enzymes, and thrombocytopenia. The clinical presentation can vary widely, ranging from mild symptoms to severe cases involving multi-organ dysfunction. In this chapter, we present a case of Class 1 HELLP syndrome that developed in the postpartum period and progressed to multi-organ failure. The patient was admitted to the intensive care unit (ICU) shortly after cesarean delivery due to oliguria, severe thrombocytopenia, marked elevation in liver enzymes, and acute renal impairment. As initial treatment modalities failed to stabilize her condition, plasmapheresis and hemodialysis were initiated, leading to significant clinical and laboratory improvement. The patient recovered without complications and was successfully discharged. This case emphasizes the importance of a multidisciplinary approach and advanced organ support therapies in managing severe HELLP syndrome.
- 31 March 2026
- Published by Academician Publishing
- p. 265-270
Miyastenia Gravis Hastasının Yoğun Bakım Yönetimi
Baryum aspirasyonunun nadir görülen, hafif semptomlarla seyredebileceği gibi ölümle sonuçlanan ciddi solunum yetmezliğine yol açabilir. Aspire edilen miktara bağlı olarak pnömoni, ARDS ve fibrozis gibi ciddi solunum komplikasyonlarının gelişebileceği belirtilmektedir. Bu olguda disfaji tanısına yönelik yapılan görüntülemede baryum aspirasyonu sonrası solunum yetmezliği gelişen hastanın yoğun bakım yönetimi ele alınmaktadır. Solunum yetmezliği ilerleyen hastaya önce noninvaziv, ardından invaziv mekanik ventilasyon desteği verilmiştir. Takiplerinde disfajiye yönelik yapılan testlerinde miyastenia graves (MG) tanısı doğrulanarak pridostigmin ve terapötik plazmaferez tedavileriyle klinik düzelme sağlanmıştır. Disfaji ile başvuran hastalarda MG’in ayırıcı tanıda mutlaka değerlendirilmesi gerektiği, tanısız MG olgularında yapılan baryumlu özofagus grafisinin aspirasyon riskini artırabileceği vurgulanmaktadır. Ayrıca, baryum aspirasyonunun yönetiminde multidisipliner yaklaşımın kritik rolü ve erken dönemde uygun tedavi yaklaşımlarının prognozu iyileştirebileceği gösterilmiştir. Özellikle nöromüsküler hastalık şüphesi olan olgularda alternatif tanısal yöntemlerin tercih edilmesi, komplikasyonların önlenmesi açısından dikkate alınmalıdır. Barium aspiration, though rare, can present with mild symptoms or progress to severe respiratory failure with potentially fatal outcomes. Depending on the volume aspirated, serious pulmonary complications such as pneumonia, acute respiratory distress syndrome (ARDS), and pulmonary fibrosis may develop. This case highlights the intensive care management of a patient who developed respiratory failure following barium aspiration during imaging performed to evaluate dysphagia. As the respiratory failure progressed, the patient initially received non-invasive mechanical ventilation, followed by invasive mechanical ventilation support. Subsequent evaluations aimed at identifying the etiology of dysphagia confirmed a diagnosis of myasthenia gravis (MG), and clinical improvement was achieved with pyridostigmine therapy and therapeutic plasmapheresis. This case underscores the importance of considering MG in the differential diagnosis of patients presenting with dysphagia, as performing barium esophagography in undiagnosed MG cases may increase the risk of aspiration. Furthermore, it emphasizes the critical role of a multidisciplinary approach in managing barium aspiration and demonstrates how early and appropriate therapeutic interventions can significantly improve prognosis. For patients with suspected neuromuscular disorders, alternative diagnostic modalities should be considered to minimize the risk of such complications.
- 31 March 2026
- Published by Academician Publishing
- p. 265-270
Miyastenia Gravis Hastasının Yoğun Bakım Yönetimi
Baryum aspirasyonunun nadir görülen, hafif semptomlarla seyredebileceği gibi ölümle sonuçlanan ciddi solunum yetmezliğine yol açabilir. Aspire edilen miktara bağlı olarak pnömoni, ARDS ve fibrozis gibi ciddi solunum komplikasyonlarının gelişebileceği belirtilmektedir. Bu olguda disfaji tanısına yönelik yapılan görüntülemede baryum aspirasyonu sonrası solunum yetmezliği gelişen hastanın yoğun bakım yönetimi ele alınmaktadır. Solunum yetmezliği ilerleyen hastaya önce noninvaziv, ardından invaziv mekanik ventilasyon desteği verilmiştir. Takiplerinde disfajiye yönelik yapılan testlerinde miyastenia graves (MG) tanısı doğrulanarak pridostigmin ve terapötik plazmaferez tedavileriyle klinik düzelme sağlanmıştır. Disfaji ile başvuran hastalarda MG’in ayırıcı tanıda mutlaka değerlendirilmesi gerektiği, tanısız MG olgularında yapılan baryumlu özofagus grafisinin aspirasyon riskini artırabileceği vurgulanmaktadır. Ayrıca, baryum aspirasyonunun yönetiminde multidisipliner yaklaşımın kritik rolü ve erken dönemde uygun tedavi yaklaşımlarının prognozu iyileştirebileceği gösterilmiştir. Özellikle nöromüsküler hastalık şüphesi olan olgularda alternatif tanısal yöntemlerin tercih edilmesi, komplikasyonların önlenmesi açısından dikkate alınmalıdır. Barium aspiration, though rare, can present with mild symptoms or progress to severe respiratory failure with potentially fatal outcomes. Depending on the volume aspirated, serious pulmonary complications such as pneumonia, acute respiratory distress syndrome (ARDS), and pulmonary fibrosis may develop. This case highlights the intensive care management of a patient who developed respiratory failure following barium aspiration during imaging performed to evaluate dysphagia. As the respiratory failure progressed, the patient initially received non-invasive mechanical ventilation, followed by invasive mechanical ventilation support. Subsequent evaluations aimed at identifying the etiology of dysphagia confirmed a diagnosis of myasthenia gravis (MG), and clinical improvement was achieved with pyridostigmine therapy and therapeutic plasmapheresis. This case underscores the importance of considering MG in the differential diagnosis of patients presenting with dysphagia, as performing barium esophagography in undiagnosed MG cases may increase the risk of aspiration. Furthermore, it emphasizes the critical role of a multidisciplinary approach in managing barium aspiration and demonstrates how early and appropriate therapeutic interventions can significantly improve prognosis. For patients with suspected neuromuscular disorders, alternative diagnostic modalities should be considered to minimize the risk of such complications.
- 31 March 2026
- Published by Academician Publishing
Olgularla Yoğun Bakım II
- 31 March 2026
- Published by Academician Publishing
- p. 187-192
Peripartum Kardiyomiyopati Tanılı Hastada Yoğun Bakım Yönetimi
Peripartum kardiyomiyopati (PPKM), daha önce bilinen kalp hastalığı olmayan kadınlarda gebeliğin son döneminde veya doğum sonrası ilk aylarda ortaya çıkan, sol ventrikül sistolik disfonksiyonu ile karakterize nadir ancak ciddi bir kalp yetmezliği tablosudur. Erken tanı ve uygun tedavi sağlanamadığında maternal morbidite ve mortalite riski yüksektir. Bu olguda, doğumdan iki hafta sonra nefes darlığı şikayeti ile başvuran 37 yaşındaki multipar bir hastanın yoğun bakım yönetimi sunulmuştur. Hastanın değerlendirilmesinde hipotansiyon, taşikardi, metabolik asidoz, multiorgan yetmezlik bulguları ve ekokardiyografide %25 ejeksiyon fraksiyonu saptanmış olup kardiyojenik şok ile komplike PPKM tanısı düşünülmüştür. Yoğun bakım ünitesinde hastaya yüksek akım oksijen tedavisi, noradrenalin ile vazopressör destek, levosimendan ile inotrop tedavi, esmolol infüzyonu ile hız kontrolü, geniş spektrum antibiyotik tedavisi ve oligüri ile ciddi metabolik asidoz nedeniyle sürekli veno-venöz hemodiyafiltrasyon uygulanmıştır. İzlem sürecinde hastanın klinik ve hemodinamik parametrelerinde belirgin düzelme sağlanmış, beşinci günde organ destek tedavileri sonlandırılmıştır. Altıncı günde kardiyoloji servisine devredilen hasta ileri izlem sonrası şifa ile taburcu edilmiştir. Bu olgu, kardiyojenik şok ve multiorgan yetmezlik ile seyreden PPKM hastalarında erken tanı, multidisipliner yaklaşım ve zamanında başlanan ileri yoğun bakım tedavisinin prognozu belirgin şekilde iyileştirebileceğini göstermektedir. Peripartum cardiomyopathy (PPCM) is a rare but serious heart failure condition characterized by left ventricular systolic dysfunction that occurs in women without previously known heart disease during the late period of pregnancy or within the first months after delivery. The risk of maternal morbidity and mortality is high when early diagnosis and appropriate treatment cannot be achieved. In this case, the intensive care management of a 37-year-old multiparous patient who presented with the complaint of dyspnea two weeks after delivery is presented. In the evaluation of the patient, hypotension, tachycardia, metabolic acidosis, findings of multiorgan failure, and an ejection fraction of 25% on echocardiography were detected, and PPCM complicated with cardiogenic shock was considered. In the intensive care unit, high-flow oxygen therapy, vasopressor support with norepinephrine, inotropic therapy with levosimendan, rate control with esmolol infusion, broad-spectrum antibiotic therapy, and continuous veno-venous hemodiafiltration due to oliguria and severe metabolic acidosis were administered. During the follow-up period, a significant improvement was achieved in the clinical and hemodynamic parameters of the patient, and organ support therapies were discontinued on the fifth day. The patient, who was transferred to the cardiology ward on the sixth day, was discharged with recovery after further follow-up. This case demonstrates that early diagnosis, a multidisciplinary approach, and timely initiated advanced intensive care treatment can significantly improve prognosis in PPCM patients presenting with cardiogenic shock and multiorgan failure.
- 31 March 2026
- Published by Academician Publishing
- p. 187-192
Peripartum Kardiyomiyopati Tanılı Hastada Yoğun Bakım Yönetimi
Peripartum kardiyomiyopati (PPKM), daha önce bilinen kalp hastalığı olmayan kadınlarda gebeliğin son döneminde veya doğum sonrası ilk aylarda ortaya çıkan, sol ventrikül sistolik disfonksiyonu ile karakterize nadir ancak ciddi bir kalp yetmezliği tablosudur. Erken tanı ve uygun tedavi sağlanamadığında maternal morbidite ve mortalite riski yüksektir. Bu olguda, doğumdan iki hafta sonra nefes darlığı şikayeti ile başvuran 37 yaşındaki multipar bir hastanın yoğun bakım yönetimi sunulmuştur. Hastanın değerlendirilmesinde hipotansiyon, taşikardi, metabolik asidoz, multiorgan yetmezlik bulguları ve ekokardiyografide %25 ejeksiyon fraksiyonu saptanmış olup kardiyojenik şok ile komplike PPKM tanısı düşünülmüştür. Yoğun bakım ünitesinde hastaya yüksek akım oksijen tedavisi, noradrenalin ile vazopressör destek, levosimendan ile inotrop tedavi, esmolol infüzyonu ile hız kontrolü, geniş spektrum antibiyotik tedavisi ve oligüri ile ciddi metabolik asidoz nedeniyle sürekli veno-venöz hemodiyafiltrasyon uygulanmıştır. İzlem sürecinde hastanın klinik ve hemodinamik parametrelerinde belirgin düzelme sağlanmış, beşinci günde organ destek tedavileri sonlandırılmıştır. Altıncı günde kardiyoloji servisine devredilen hasta ileri izlem sonrası şifa ile taburcu edilmiştir. Bu olgu, kardiyojenik şok ve multiorgan yetmezlik ile seyreden PPKM hastalarında erken tanı, multidisipliner yaklaşım ve zamanında başlanan ileri yoğun bakım tedavisinin prognozu belirgin şekilde iyileştirebileceğini göstermektedir. Peripartum cardiomyopathy (PPCM) is a rare but serious heart failure condition characterized by left ventricular systolic dysfunction that occurs in women without previously known heart disease during the late period of pregnancy or within the first months after delivery. The risk of maternal morbidity and mortality is high when early diagnosis and appropriate treatment cannot be achieved. In this case, the intensive care management of a 37-year-old multiparous patient who presented with the complaint of dyspnea two weeks after delivery is presented. In the evaluation of the patient, hypotension, tachycardia, metabolic acidosis, findings of multiorgan failure, and an ejection fraction of 25% on echocardiography were detected, and PPCM complicated with cardiogenic shock was considered. In the intensive care unit, high-flow oxygen therapy, vasopressor support with norepinephrine, inotropic therapy with levosimendan, rate control with esmolol infusion, broad-spectrum antibiotic therapy, and continuous veno-venous hemodiafiltration due to oliguria and severe metabolic acidosis were administered. During the follow-up period, a significant improvement was achieved in the clinical and hemodynamic parameters of the patient, and organ support therapies were discontinued on the fifth day. The patient, who was transferred to the cardiology ward on the sixth day, was discharged with recovery after further follow-up. This case demonstrates that early diagnosis, a multidisciplinary approach, and timely initiated advanced intensive care treatment can significantly improve prognosis in PPCM patients presenting with cardiogenic shock and multiorgan failure.
- 31 March 2026
- Published by Academician Publishing
- p. 205-210
Digoksin Zehirlenmesinde Yoğun Bakım Yönetimi
Digoksin, kalp yetmezliği ve atriyal fibrilasyon tedavisinde kullanılan dar terapötik indekse sahip bir kardiyak glikozittir. Özellikle ileri yaş, böbrek yetmezliği ve elektrolit dengesizlikleri olan hastalarda toksisite riski artmaktadır. Digoksin zehirlenmesi; bradikardi, iletim bozuklukları, ventriküler aritmiler, gastrointestinal ve nörolojik semptomlarla seyredebilir ve mortal sonuçlara yol açabilir. Bu bölümde digoksinin farmakokinetik özellikleri, toksisite mekanizmaları, klinik bulguları, EKG değişiklikleri ve güncel tedavi yaklaşımları ayrıntılı olarak ele alınmaktadır. Ayrıca ileri yaş, kronik böbrek hastalığı ve sepsis eşlik eden bir olgu üzerinden yoğun bakım yönetimi tartışılmaktadır. Tedavi yaklaşımında ilacın kesilmesi, elektrolit düzeltilmesi, semptomatik destek, geçici pacemaker uygulaması ve gerekli durumlarda digoksin immün Fab kullanımı yer almaktadır. Yüksek riskli hastalarda doz ayarlaması ve yakın serum düzeyi takibi mortaliteyi azaltmada kritik öneme sahiptir. Digoxin is a cardiac glycoside with a narrow therapeutic index, commonly used in heart failure and atrial fibrillation. The risk of toxicity increases particularly in elderly patients, those with renal impairment, and individuals with electrolyte disturbances. Digoxin intoxication may present with bradycardia, conduction abnormalities, ventricular arrhythmias, and gastrointestinal or neurological symptoms, potentially leading to fatal outcomes.This chapter reviews the pharmacokinetic properties of digoxin, mechanisms of toxicity, clinical manifestations, characteristic ECG findings, and current treatment strategies. A case involving an elderly patient with chronic kidney disease and sepsis is presented to illustrate intensive care management principles.Treatment includes discontinuation of digoxin, correction of electrolyte imbalances, supportive care, temporary pacing when indicated, and administration of digoxin-specific antibody fragments (digoxin immune Fab) in life-threatening cases. Dose adjustment and close therapeutic drug monitoring are essential in high-risk patients to reduce morbidity and mortality.
- 31 March 2026
- Published by Academician Publishing
- p. 205-210
Digoksin Zehirlenmesinde Yoğun Bakım Yönetimi
Digoksin, kalp yetmezliği ve atriyal fibrilasyon tedavisinde kullanılan dar terapötik indekse sahip bir kardiyak glikozittir. Özellikle ileri yaş, böbrek yetmezliği ve elektrolit dengesizlikleri olan hastalarda toksisite riski artmaktadır. Digoksin zehirlenmesi; bradikardi, iletim bozuklukları, ventriküler aritmiler, gastrointestinal ve nörolojik semptomlarla seyredebilir ve mortal sonuçlara yol açabilir. Bu bölümde digoksinin farmakokinetik özellikleri, toksisite mekanizmaları, klinik bulguları, EKG değişiklikleri ve güncel tedavi yaklaşımları ayrıntılı olarak ele alınmaktadır. Ayrıca ileri yaş, kronik böbrek hastalığı ve sepsis eşlik eden bir olgu üzerinden yoğun bakım yönetimi tartışılmaktadır. Tedavi yaklaşımında ilacın kesilmesi, elektrolit düzeltilmesi, semptomatik destek, geçici pacemaker uygulaması ve gerekli durumlarda digoksin immün Fab kullanımı yer almaktadır. Yüksek riskli hastalarda doz ayarlaması ve yakın serum düzeyi takibi mortaliteyi azaltmada kritik öneme sahiptir. Digoxin is a cardiac glycoside with a narrow therapeutic index, commonly used in heart failure and atrial fibrillation. The risk of toxicity increases particularly in elderly patients, those with renal impairment, and individuals with electrolyte disturbances. Digoxin intoxication may present with bradycardia, conduction abnormalities, ventricular arrhythmias, and gastrointestinal or neurological symptoms, potentially leading to fatal outcomes.This chapter reviews the pharmacokinetic properties of digoxin, mechanisms of toxicity, clinical manifestations, characteristic ECG findings, and current treatment strategies. A case involving an elderly patient with chronic kidney disease and sepsis is presented to illustrate intensive care management principles.Treatment includes discontinuation of digoxin, correction of electrolyte imbalances, supportive care, temporary pacing when indicated, and administration of digoxin-specific antibody fragments (digoxin immune Fab) in life-threatening cases. Dose adjustment and close therapeutic drug monitoring are essential in high-risk patients to reduce morbidity and mortality.
- 9 February 2026
- Published by MediHealth Academy in Eurasian Journal of Anesthesiology and Intensive Care
- Vol. 3 (1) , 16-21
Length of stay in intensive care unit and factors associated with clinical outcomes in patients with postoperative intracranial masses
Aims: This study aimed to evaluate factors associated with intensive care unit (ICU) length of stay (LOS) and mortality in patients who underwent surgical intervention for postoperative intracranial masses and required ICU monitoring. Methods: This retrospective, single-center observational study included adult patients who underwent intracranial mass surgery and were followed in the ICU for at least 48 hours between January 2017 and December 2025. Demographic characteristics, comorbidities, tumor-related variables, clinical scores (Glasgow Coma Scale and APACHE II), need for and duration of mechanical ventilation, ICU complications, LOS, and mortality were recorded. Prolonged ICU stay was defined as >3 days. Univariate and multivariate logistic regression analyses were performed to identify independent predictors of prolonged ICU stay. Results: A total of 128 patients were included. The median ICU LOS was 3 days, and ICU mortality was 25.8%. Mechanical ventilation requirement, ventilation duration, respiratory complications, and higher APACHE II scores were significantly associated with both ICU LOS and mortality. In multivariate analysis, the APACHE II score was the only independent predictor of prolonged ICU stay (OR: 0.924, 95% CI: 0.862–0.991; p = 0.027). Tumor type showed an association with ICU LOS in univariate analyses, whereas tumor location was not independently associated with outcomes. Conclusion: In patients with postoperative intracranial masses, ICU LOS and mortality are primarily influenced by acute clinical severity and systemic complications rather than tumor characteristics. The APACHE II score is an independent predictor of prolonged ICU stay, highlighting the importance of early risk stratification to optimize ICU resource utilization.
- 9 February 2026
- Published by MediHealth Academy in Eurasian Journal of Anesthesiology and Intensive Care
- Vol. 3 (1) , 16-21
Length of stay in intensive care unit and factors associated with clinical outcomes in patients with postoperative intracranial masses
Aims: This study aimed to evaluate factors associated with intensive care unit (ICU) length of stay (LOS) and mortality in patients who underwent surgical intervention for postoperative intracranial masses and required ICU monitoring. Methods: This retrospective, single-center observational study included adult patients who underwent intracranial mass surgery and were followed in the ICU for at least 48 hours between January 2017 and December 2025. Demographic characteristics, comorbidities, tumor-related variables, clinical scores (Glasgow Coma Scale and APACHE II), need for and duration of mechanical ventilation, ICU complications, LOS, and mortality were recorded. Prolonged ICU stay was defined as >3 days. Univariate and multivariate logistic regression analyses were performed to identify independent predictors of prolonged ICU stay. Results: A total of 128 patients were included. The median ICU LOS was 3 days, and ICU mortality was 25.8%. Mechanical ventilation requirement, ventilation duration, respiratory complications, and higher APACHE II scores were significantly associated with both ICU LOS and mortality. In multivariate analysis, the APACHE II score was the only independent predictor of prolonged ICU stay (OR: 0.924, 95% CI: 0.862–0.991; p = 0.027). Tumor type showed an association with ICU LOS in univariate analyses, whereas tumor location was not independently associated with outcomes. Conclusion: In patients with postoperative intracranial masses, ICU LOS and mortality are primarily influenced by acute clinical severity and systemic complications rather than tumor characteristics. The APACHE II score is an independent predictor of prolonged ICU stay, highlighting the importance of early risk stratification to optimize ICU resource utilization.
- Open Access
- 31 January 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (3) , 1210-1219
The Impact of Intraoperative Position Changes on Hemodynamics and Cardiac Electrophysiological Balance Index in Patients with Severe Obesity Undergoing Laparoscopic Sleeve Gastrectomy
Background: Pneumoperitoneum and the reverse Trendelenburg (RT) position during laparoscopic sleeve gastrectomy (LSG) can induce autonomic instability and increase the risk of arrhythmias by reducing venous return. This study aimed to evaluate the impact of surgical positioning during LSG on autonomic cardiac function, using hemodynamic parameters and the cardiac electrophysiological balance index (iCEB = QT/QRS) as a biomarker. Methods: This prospective observational study included 66 patients with severe obesity who underwent LSG. Measurements were recorded at five distinct time points, corresponding to specific patient positioning during the procedure: P-baseline (before induction, supine), P1 (after induction, supine), P2 (after pneumoperitoneum, supine), P3 (during pneumoperitoneum, RT), and P4 (after desufflation, RT). Results: Systolic, diastolic, and mean arterial pressures (SAP, DAP, and MAP) significantly decreased at all positions compared to baseline ( p < 0.001 for each). Compared to post-induction (P1), SAP values were substantially higher in the P2 and P4 positions ( p < 0.05, p < 0.001, respectively). Heart rate significantly decreased at P1 compared to baseline ( p < 0.004) and subsequently increased at P2 and P3 relative to P1 ( p < 0.001 and p < 0.009, respectively). A notable increase in iCEB was observed at P4 when compared to P1, P2, and P3 ( p < 0.003, p < 0.001, and p < 0.021, respectively). Despite these changes, iCEB values remained within the reference range across all measured positions. Conclusion: Despite the observed effects of positional changes and pneumoperitoneum on hemodynamic and cardiac electrical parameters during LSG, most patients tolerated these changes well. Crucially, iCEB values remained within the normal reference range throughout the procedure, indicating preserved cardiac autonomic regulation.
- 31 January 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (3) , 1210-1219
Open AccessThe Impact of Intraoperative Position Changes on Hemodynamics and Cardiac Electrophysiological Balance Index in Patients with Severe Obesity Undergoing Laparoscopic Sleeve Gastrectomy
Background: Pneumoperitoneum and the reverse Trendelenburg (RT) position during laparoscopic sleeve gastrectomy (LSG) can induce autonomic instability and increase the risk of arrhythmias by reducing venous return. This study aimed to evaluate the impact of surgical positioning during LSG on autonomic cardiac function, using hemodynamic parameters and the cardiac electrophysiological balance index (iCEB = QT/QRS) as a biomarker. Methods: This prospective observational study included 66 patients with severe obesity who underwent LSG. Measurements were recorded at five distinct time points, corresponding to specific patient positioning during the procedure: P-baseline (before induction, supine), P1 (after induction, supine), P2 (after pneumoperitoneum, supine), P3 (during pneumoperitoneum, RT), and P4 (after desufflation, RT). Results: Systolic, diastolic, and mean arterial pressures (SAP, DAP, and MAP) significantly decreased at all positions compared to baseline ( p < 0.001 for each). Compared to post-induction (P1), SAP values were substantially higher in the P2 and P4 positions ( p < 0.05, p < 0.001, respectively). Heart rate significantly decreased at P1 compared to baseline ( p < 0.004) and subsequently increased at P2 and P3 relative to P1 ( p < 0.001 and p < 0.009, respectively). A notable increase in iCEB was observed at P4 when compared to P1, P2, and P3 ( p < 0.003, p < 0.001, and p < 0.021, respectively). Despite these changes, iCEB values remained within the reference range across all measured positions. Conclusion: Despite the observed effects of positional changes and pneumoperitoneum on hemodynamic and cardiac electrical parameters during LSG, most patients tolerated these changes well. Crucially, iCEB values remained within the normal reference range throughout the procedure, indicating preserved cardiac autonomic regulation.